Recordati’s Post

Our ethos revolves around fostering enduring relationships that transcend mere transactions, embodying a philosophy deeply rooted in trust, empathy, and shared vision. We adapt, we listen, and we evolve alongside our partners, forging bonds that endure the test of time and shape the future of Pharmaceutical industry. 📈 The numbers speak volumes: from zero licenses upon our establishment in 2022 to over 80 granted licenses in the Baltics by the third quarter of 2023. These milestones underscore our rapid growth and the trust placed in us by healthcare professionals across the region. In an ever-evolving pharmaceutical landscape, our commitment to long-term relationship-building isn't just a strategic imperative—it's our enduring legacy. 🌱💡 #Pharmacy #RelationshipBuilding #HealthcarePartnerships #FutureOfHealthcare #Niromed

At Sandoz, we believe that driving biosimilar adoption can support more equitable access to high-quality healthcare and improve outcomes for patients across the globe. We’re excited about the opportunity to foster Day 1 access to generics and biosimilars in Europe, improve supply chain resilience and simplify the regulatory framework with the ongoing EU Pharma Review 🌍 This week, Rebecca Guntern, President Region Europe and Country President Switzerland, and Peter Stenico, Global Head of Biosimilars and Country President Austria, spoke at Reuters Events Pharma where they shared their insights on the importance of revising the EU pharmaceutical legislation, regulatory streamlining, and the adoption of smarter procurement processes to increase access to generics and biosimilars in Europe. See below for some key takeaways from Rebecca and Peter 👇 #Biosimilars #Healthcare #REPharma2024 http://bit.ly/43Qc64c

Zentiva is at the forefront of ensuring sustainable healthcare in Europe and our CEO Steffen Saltofte reinforced that commitment at the inaugural launch of the EU's Critical Medicines Alliance.    Industry leaders and policymakers met in Brussels to advance the stability and accessibility of medicine supplies throughout Europe.     With robust manufacturing sites in the Czech Republic and Romania, and a team of more than 5,000 people, Zentiva is a cornerstone in Europe’s pharmaceutical industry. We are devoted to supporting the EU's vision of building a robust healthcare system that ensures high-quality, accessible pharmaceutical solutions are available to all.     Our participation in the Alliance underscores our commitment. We will continue to advocate for policies that enhance the growth of a resilient European healthcare systems. We focus on the continuity and security of medicine supplies, crucial for patient care across the continent.     #Zentiva #CriticalMedicinesAlliance #MedicineAccessibility #Accesstohealthcare

Trend Watch 🌐 Amidst the evolving landscape of #pharmaceutical economics, stability in essential #drug prices signifies a positive trend for both patients and #healthcare providers. It's a testament to collaborative efforts within the sector to prioritize #affordability and access. This trend reaffirms the significance of staying informed and up-to-date with industry developments 💊 At MedFisher, we're committed to organizing #events that serve as invaluable platforms for our audience to receive first-hand, accurate insights from top experts in the field. Through collaborative partnerships, #innovative technologies, and evidence-based advocacy, we aim to drive systemic change and ensure #equitable healthcare for all 🌟 #PharmaInsights #HealthcareEquity #BuildingBridges

Join the National Pharmaceutical Congress Spring Webinar today at 11:00! 📅 Date: Wednesday, May 29, 2024   ⏰ Time: 11 a.m. to 12 p.m. EDT   📍 Virtual Event Register for free today: https://lnkd.in/g8UDjFDv As the debate rages over Canada's proposed national pharmacare program, this highly anticipated webinar will cut through the noise to shed light on the myths and facts surrounding Bill C-64. Our esteemed panel will explore the concerns raised about drug shortages, lost workplace benefits, and effects on the pharmaceutical industry. At the same time, we'll examine how pharmacare could potentially reduce costs and improve medication affordability and access for Canadians. With much still uncertain, get invaluable insights from existing universal drug plans as we separate fact from fiction on this major healthcare reform. Join us as we delve into strategies for protecting Canadian patients' right to choose during these challenging times. Register for free today: https://lnkd.in/g8UDjFDv Don't miss this opportunity to gain a deeper understanding of the proposed pharmacare program and its potential impact on the healthcare landscape. #Pharmacare #BillC64 #HealthcareReform #NationalPharmaceuticalCongress #Webinar #CanadianHealthcare

Let's delve into the fascinating world of the Brazilian medical market. With its impressive $13 billion size, Brazil ranks among the top 10 largest medical markets globally. The sheer scale is truly enormous! Approximately half of this market value is dedicated to domestic consumption, including the thriving pharmaceutical industry, which accounts for $25 billion. 👥 Brazil's population of 200 million, coupled with its growing GDP, creates a dynamic landscape that sets it apart from other markets. Tailor your strategies to meet the evolving demands of this vast and diverse landscape. Collaborate with local and international partners, leverage the growing middle-class segment, and position your products for success. So, what are the key characteristics that make the Brazilian medical market unique? 👇 #healthcarebrazil #medicalmarket #globalsalesmentor #internationalsales

🟢In the pharmaceutical industry, where serving humanity is an essential element, DEMO places the benefit of society at the core of its Corporate Social Responsibility. Through our actions, we prioritize people, faithfully serving our vision of ensuring access to quality healthcare for everyone. 
 #DemoSA #AlwaysForward #CSR #SocialResponsibility #PharmaceuticalIndustry

It's not too late to register for tomorrow's webinar on the Inflation Reduction Act (IRA)! Join Leeann Lui, Holli Kawadler, Patricia Goldsmith, and Abigail Johnston as they discuss: - how the provisions of the IRA will impact patients - how the provisions of the IRA will help patients and advocacy organizations navigate its current and future impact - the critical importance of the patient perspective to pharmaceutical manufacturers Register at https://buff.ly/4f7iI2N #InflationReductionAct #IRA #HealthCarePolicy #PatientAdvocacy #PatientPerspective #PatientAccess #MedicarePartD #HealthcareInnovation

Check out our latest blog post if you're interested in learning about some of the downstream effects of CMS's Drug Price Negotiation Program. Thanks to Scott Briggs and Matthew Riordan for the partnership on this!

Did you know that the UAE’s pharmaceutical market is on track to soar to $5.7 billion by 2024? With a burgeoning population and rising healthcare spending, explore the dynamic landscape of pharmacy every Friday for captivating insights and trends! #UAEPharma #HealthcareTrends #PharmacyInsights #FutureOfMedicine #HealthcareIndustry #UAEHealthcare #PharmaMarket #FridayFacts